I suspect the single $8M customer may be from the SPEIK business who they acquired 3 years ago with $12M annual revenues.
Those administration expenses are ridiculous, $3.3M in consultants and $2M in travel for such a small management team.
The other worrying factor in the back of mind is when the implications of laying off the sales force to reduce spend might kick in. I am not sure the effect of that has really been felt yet as the sales pipeline is very long for this tech.When you remove all the spin and noise from the quarterly’s the customer receipts haven’t been moving in the upward trajectory the carefully crafted graphs would indicate.
CUSTOMER RECEIPTS:
DEC23 - $8.8M
SEP23 - $9.0M
JUN23 - $10.2M
MAR23 - $8.1M
DEC22 - $8.3M
SEP22 - $9.5M
JUN22 - $6.7M
MAR22 - $8.5M
DEC21 - $5.6M
SEP21 - $9.1M
- Forums
- ASX - By Stock
- DUB
- Dubber.Dubber.Do.
Dubber.Dubber.Do., page-7726
Featured News
Add DUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $43.99M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.0¢ | $149.4K | 6.970M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 2811746 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 942981 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 2811746 | 0.020 |
3 | 1152680 | 0.019 |
9 | 1886370 | 0.018 |
7 | 2128940 | 0.017 |
25 | 5928792 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 942981 | 1 |
0.022 | 152 | 1 |
0.023 | 101500 | 2 |
0.024 | 1693574 | 3 |
0.025 | 400000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online